Skip to content

Clinical trials

Expanded access trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Expanded access Country / region: Brazil Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20081
20141

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available17
Approved for marketing12
Available2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
Janssen Research & Development, LLC3
Novartis Pharmaceuticals3
Amgen2
Boehringer Ingelheim2
Eli Lilly and Company2
Janssen-Cilag Farmaceutica Ltda.2
Pfizer2
Aragon Pharmaceuticals, Inc.1
Astellas Pharma Global Development, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Recurrence2
Adenocarcinoma1
Anemia, Sickle Cell1
Bites and Stings1
Breast Neoplasms1
Carcinoma, Renal Cell1
Chronic Pain1
Crohn Disease1

Trials

Showing 51 to 31 of 31. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.